Acura Pharmaceuticals, Inc. announced that it has received $2,319,279 through a secured promissory note on November 10, 2022. The transaction included participation from returning investor, Abuse Deterrent Pharma, LLC. The note bears interest at 5.25%, and matures on December 31, 2023, at which time all principal and interest is due.

Events of default under the note include, among other items, bankruptcy events, failure to pay interest and principal when due and such failure continues for 5 days, and if company is generally not, or is unable to, or admits in writing its inability to, pay its debts as they become due.